Considering these results might account for the IDH1 mutation occurring in glioma (39), we analyzed IDH1 in specific tumors, including LGG and GBM in the TCGA cohort (Figure 5F, Supplementary Figure 4D); IDH1 exhibited the highest mutation frequency in TCGA LGG cohort (77%). The gene discussed is IDH1; the disease is central nervous system cancer.